Boeing Lags Peers After Q3 Print as Analysts Keep Trimming

BA gained 2.1% over the past week, but that trails the median move of 5.6% across its closest aerospace and defense peers, several of which have seen notably stronger recoveries in recent days.

Among the names most correlated with Boeing, HII rose 5.6% on the week and RTX added 5.6%, while GE fell 2.5%. SARO was the standout, up nearly 8%. The divergence is worth noting because it does not reflect unusual short pressure on Boeing itself: short interest is just under 2% of the free float, down about 2% on the week and down 7% over the past month. Borrow availability is enormous at over 4,600%, roughly 46 times the shares currently borrowed, so the lending market offers no resistance to anyone wanting to increase a position in either direction. The stock at $190.47 remains well below the Street's mean target, which has been compressed by repeated cuts but still implies meaningful distance from the current price.

The analyst picture is the more active variable right now. Morgan Stanley's Kristine Liwag cut her target to $225 from $250 on October 19, maintaining Equal-Weight, making her the most recent voice to lower the bar just after the Q3 print. That follows RBC Capital's trim to $235 from $265 on October 15 and Bernstein's reduction to $278 from $298 on October 12. The direction of travel is consistent: firms with positive ratings are keeping them but pulling targets closer to where the stock actually trades. The broad consensus remains constructive, with EPS momentum factor scores ranked in the 91st percentile on a 30-day basis and the 97th over 90 days, reflecting a run of positive estimate revisions. But the forward earnings multiple has compressed, with the P/E falling roughly 8 points over the past 30 days to 68x, and return on capital is still negative, which the bear case pins as the central flaw in the recovery story.

The bull case rests on operational momentum. Q2 2026 showed revenue up 8% year on year to $24.6 billion, positive free cash flow of $631 million, and 171 commercial aircraft delivered. The $715 billion order backlog gives the company rare multi-year demand visibility. The bear case is that none of this yet translates into durable capital efficiency: NOPAT was a $4.52 billion loss over the trailing twelve months, and return on capital remained negative at around -7%. The gap between improving top-line metrics and still-absent profitability is where the stock's discount to analyst targets lives.

Options positioning has settled into neutral territory. The put/call ratio is 0.84, just above its 20-day average of 0.82 and less than one standard deviation from that mean. There is no strong lean in either direction, which is consistent with a stock that has just reported and is now waiting for the next catalyst rather than pricing one in. Wikipedia attention is running above Boeing's own 90-day history with a z-score near 1.3, suggesting the Q3 print generated some retail interest, but that is a measure of attention rather than any indicator of financial performance.

The one level worth tracking is whether analyst targets continue to converge toward the current price or stabilise. The spread between the current price and mean target has already narrowed materially through October's wave of cuts, and another round of reductions following the Q3 results would change the character of the setup from "cheap relative to consensus" to something more contested.